NHD Global
Incretin receptor agonists are among the most actively studied peptide classes in metabolic research. This group covers single, dual and triple receptor agonists alongside the amylin analogues and lipolytic sequences frequently used with them.
Catalog materials are presented for research use. Analytical methods and lot-document availability vary by material and must be confirmed from the applicable specification and records.
Continue from catalog navigation into editorial analysis, evidence records and quality-documentation guidance.
Showing 1–6 of 16 reviewed articles · Page 1 of 3
AICAR naming often collapses acadesine, its intracellular phosphorylated metabolite ZMP and an entire AMPK pathway into one label. Reproducible research needs those…
Lire la revue des sources →A 2024 study reported prevention and reversal of neuropathy measures after experimental AICAR exposure in mouse models of type 1 and type…
Lire la revue des sources →AOD-9604 is a modified growth-hormone fragment developed around a lipolysis hypothesis. Preclinical plausibility and early development do not override the larger null…
Lire la revue des sources →AOD-9604 progressed beyond animal work into an obesity-development program. FDA’s 2024 review records that the large OPTIONS study did not show statistically…
Lire la revue des sources →“Human” in a MOTS-c catalog title ordinarily describes the referenced peptide sequence; it does not mean the material was isolated from a…
Lire la revue des sources →L'article qui présente le MOTS-c combine des expériences cellulaires avec des modèles métaboliques de souris. Il s’agit d’un dossier de découverte important, mais les résultats de l’intervention…
Lire la revue des sources →If a target is not listed, submit the sequence, scale and specification for a custom-project feasibility review.
Indiquez-nous vos besoins. Votre demande sera transmise à l’interlocuteur compétent pour les références, la disponibilité et les détails du devis.
